Esteban Braggio

Assistant Professor

Mayo Clinic

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Esteban Braggio is an Assistant Professor at Mayo Clinic in the United States. His research areas focus on hematological malignancies, including multiple myeloma and chronic lymphocytic leukemia (CLL), with particular interest in T cell defects, genomic landscapes, and therapeutic interventions. He has contributed to significant studies, such as the correlation of T cell defects with disease outcomes and the genomic complexities of extramedullary myeloma.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

David G. Coffey

Assistant Professor

University of Miami School of Medicine

UNITED STATES

View details

Bachisio Ziccheddu

Sylvester Comprehensive Cancer Center, University of Miami

UNITED STATES

View details

Alan Ramsay

King’s College London

UNITED KINGDOM

View details

SUTAPA SINHA

Assistant professor

Mayo Clinic

UNITED STATES

View details

Susan O’Brien

UNITED STATES

View details

Jacqueline Claudia Barrientos

Professor

Northwell Health

UNITED STATES

View details

Wei Ding

Associate Professor of Medicine, Consultant

Mayo Clinic Minnesota

UNITED STATES

View details

Jian Zhong

Stony Brook University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Esteban Braggio

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912

Progressive T cell defects correlate with disease outcome in high-count monoclonal B-cell lymphocytosis

Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations

Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention

The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans.

Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis

Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease

Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib

B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells

Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis

CLL-506 Clinical Outcomes Beyond Progression on Ibrutinib in Patients With Chronic Lymphocytic Leukemia

Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia

Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome

Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patients

Collaborators (8)

David G. Coffey

Bachisio Ziccheddu

Alan Ramsay

SUTAPA SINHA

Susan O’Brien

Jacqueline Claudia Barrientos

Wei Ding

Jian Zhong

Make your next move.